U.S. pharma huge copyright scrapped two experimental weight loss tablets past yr—a the moment-every day pill, lotiglipron, resulting from elevated liver enzymes and a 2 times-everyday tablet, danuglipron, as a result of solid Uncomfortable side effects—but CEO Albert Bourla has expla